Status:
COMPLETED
Pulsed Dye Laser in Treating Patients With Post Radiation Dysphonia
Lead Sponsor:
Wake Forest University Health Sciences
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Oral Complications of Radiation Therapy
Stage I Laryngeal Cancer
Eligibility:
All Genders
Phase:
NA
Brief Summary
This pilot trial studies pulsed dye laser in treating patients with post radiation dysphonia. Dysphonia, or vocal cord scarring, can include trouble with the voice when trying to talk, such as hoarsen...
Detailed Description
PRIMARY OBJECTIVES: I. To evaluate the use of pulsed dye laser in treatment of the dysphonia that commonly results after radiation therapy for laryngeal carcinoma. OUTLINE: Patients undergo pulsed ...
Eligibility Criteria
Inclusion
- Patients suffering from dysphonia after radiation therapy for glottic carcinoma will be included in the study
- Patients will be included if their initial stage was T1 N0 M0 or T2 N0 M0
Exclusion
- Patients having previously undergone large surgical resections of the larynx or hypopharynx will be excluded
- Patients fewer than 1 year out from completion of radiation therapy will be excluded
- Patients with local disease recurrence would be excluded from the trial
- Patients in whom the transnasal endoscope is poorly tolerated or patients in whom transnasal endoscopic laryngoscopy is contraindicated will be excluded
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2016
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT02198131
Start Date
October 1 2009
End Date
June 1 2016
Last Update
April 26 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Comprehensive Cancer Center of Wake Forest University
Winston-Salem, North Carolina, United States, 27157